American Renal Associates Holdings, Inc
ARA
ARA was delisted on the 25th of January, 2021.
63 hedge funds and large institutions have $176M invested in American Renal Associates Holdings, Inc in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 13 closing their positions.
70% more call options, than puts
Call options by funds: $177K | Put options by funds: $104K
33% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 18
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.8% less ownership
Funds ownership: 86.27% → 85.47% (-0.8%)
6% less funds holding
Funds holding: 67 → 63 (-4)
16% less capital invested
Capital invested by funds: $208M → $176M (-$32.5M)
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$2.28M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$1.21M |
| 3 |
State Street
Boston,
Massachusetts
|
+$677K |
| 4 |
D.E. Shaw & Co
New York
|
+$650K |
| 5 |
BlackRock
New York
|
+$370K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.73M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.64M |
| 3 |
JP Morgan Chase
New York
|
-$1.18M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$684K |
| 5 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
-$416K |
ARA Hedge Fund Activity: Q3 2019 in Review
63 of the 4,575 institutional investors tracked by Wall St. Rank reported a position in American Renal Associates Holdings, Inc (ARA) for Q3 2019, worth a combined $176M — down 16% from $208M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of ARA and 9 opened new positions — a net loss of 4 holders — while 18 trimmed existing stakes and 24 added.
The largest buyer was Renaissance Technologies, adding an estimated $2.28M. The largest seller was Federated Hermes, cutting an estimated $2.73M.
- 63 institutional investors held American Renal Associates Holdings, Inc (ARA) as of Q3 2019, down from 67 in Q2 2019.
- Funds reported $176M of American Renal Associates Holdings, Inc stock for Q3 2019, down 16% quarter-over-quarter.
- 9 funds opened new American Renal Associates Holdings, Inc positions in Q3 2019 and 13 closed out, a net change of -4 holders.
- The largest American Renal Associates Holdings, Inc buyer in Q3 2019 was Renaissance Technologies, an estimated $2.28M added.
- The largest American Renal Associates Holdings, Inc seller in Q3 2019 was Federated Hermes, an estimated $2.73M sold.
Based on aggregated 13F filings for Q3 2019.